Diacomit

Active Ingredient(s): Stiripentol
FDA Approved: * August 20, 2018
Pharm Company: * BIOCODEX SA
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Diacomit Overview

Stiripentol (marketed as Diacomit by Laboratoires Biocodex) is an anticonvulsant drug used in the treatment of epilepsy. It is approved for the treatment of Dravet syndrome, an epilepsy syndrome. It is unrelated to other anticonvulsants and belongs to the group of aromatic allylic alcohols. Contents 1 Medical use 2 Adverse effects 3 Interactions 4 Pharmacology 5 Chemistry 6 History 7 References Medical use It is used in some countries as an add-on therapy with sodium valproate and clob...

Read more Diacomit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Stiripentol

Recent Diacomit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Stiripentol

Capsule: 250mg, 500mg
For Suspension: 250mg/packet, 500mg/packet

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Diacomit: (4 results)

Sorted by National Drug Code

68418-7939 Diacomit 250 mg Oral Capsule by Biocodex Inc.
68418-7940 Diacomit 500 mg Oral Capsule by Biocodex Inc.
68418-7941 Diacomit 1 mg/mg Oral Powder, for Suspension by Biocodex Inc.
68418-7942 Diacomit 1 mg/mg Oral Powder, for Suspension by Biocodex Inc.

Other drugs which contain Stiripentol or a similar ingredient: (1 result)

STIRIPENTOL